EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quetiapine Moderates Doxorubicin-Induced Cognitive Deficits: Influence of Oxidative Stress, Neuroinflammation, and Cellular Apoptosis

Vasudevan Mani iD, Bander Shehail Alshammeri

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Vasudevan Mani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia. Hauptthemen laut MEDLINE: NF-kappa B, Cognitive Dysfunction. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qassim University, Deanship of Scientific Research, Qassim University, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy is considered a major choice in cancer treatment. Unfortunately, several cognitive deficiencies and psychiatric complications have been reported in patients with cancer during treatment and for the rest of their lives. Doxorubicin (DOX) plays an important role in chemotherapy regimens but affects both the central and peripheral nervous systems. Antipsychotic drugs alleviate the behavioral symptoms of aging-related dementia, and the atypical class, quetiapine (QUET), has been shown to have beneficial effects on various cognitive impairments. The present investigation aimed to determine the possible mechanism underlying the effect of thirty-day administrations of QUET (10 or 20 mg/kg, p.o.) on DOX-induced cognitive deficits (DICDs). DICDs were achieved through four doses of DOX (2 mg/kg, i.p.) at an interval of seven days during drug treatment. Elevated plus maze (EPM), novel object recognition (NOR), and Y-maze tasks were performed to confirm the DICDs and find the impact of QUET on them. The ELISA tests were executed with oxidative [malondialdehyde (MDA), catalase, and reduced glutathione (GSH)], inflammatory [cyclooxygenase-2 (COX-2), nuclear factor kappa B (NF-κB), and tumor necrosis factor-alpha (TNF-α)], and apoptosis [B-cell lymphoma 2 (Bcl2), Bcl2 associated X protein (Bax), and Caspase-3] markers were assessed in the brain homogenate to explore the related mechanisms. DICD lengthened the transfer latency time in EPM, shortened the exploration time of the novel object, reduced the discrimination ability of the objects in NOR, and lowered the number of arm entries and time spent in the novel arm. QUET alleviated DICD-related symptoms. In addition, QUET reduced neuronal oxidative stress by reducing MDA and elevating GSH levels in the rat brain. Moreover, it reduced neuronal inflammation by controlling the levels of COX-2, NF-κB, and TNF-α. By improving the Bcl-2 level and reducing both Bax and Caspase-3 levels, it protected against neuronal apoptosis. Collectively, our results supported that QUET may protect against DICD, which could be explained by the inhibition of neuronal inflammation and the attenuation of cellular apoptosis protecting against oxidative stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BCognitive DysfunctionRatsAnimalsbcl-2-Associated X ProteinQuetiapine FumarateCaspase 3Neuroinflammatory DiseasesTumor Necrosis Factor-alphaCyclooxygenase 2Oxidative StressDoxorubicinApoptosisInflammationCognition

Stichwörter der Autor:innen

apoptosisatypical antipsychotic drugschemotherapy-induced cognitive deficitsneuroinflammationoxidative stress

Substanzen

bcl-2-Associated X ProteinQuetiapine FumarateCaspase 3NF-kappa BTumor Necrosis Factor-alphaCyclooxygenase 2Doxorubicin

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.

ORCID-Profile: Vasudevan Mani

Förderung

  • Qassim University
  • Deanship of Scientific Research, Qassim University, Saudi Arabia

Zitieren

APA

Mani, V., & Alshammeri, B. S. (2023). Quetiapine Moderates Doxorubicin-Induced Cognitive Deficits: Influence of Oxidative Stress, Neuroinflammation, and Cellular Apoptosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411525

Vancouver

Mani V, Alshammeri BS. Quetiapine Moderates Doxorubicin-Induced Cognitive Deficits: Influence of Oxidative Stress, Neuroinflammation, and Cellular Apoptosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411525

BibTeX
@article{Mani2023,
  author = {Mani, Vasudevan and Alshammeri, Bander Shehail},
  title = {Quetiapine Moderates Doxorubicin-Induced Cognitive Deficits: Influence of Oxidative Stress, Neuroinflammation, and Cellular Apoptosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411525}
}
Kostenlos starten →